S. Sirois

发表

Anti-SARS drug screening by molecular docking

K.-C. Chou, K. Chou, X. Zhang, 2006, Amino Acids.

Progress in computational approach to drug development against SARS.

K. Chou, Dongqing Wei, Q. Du, 2006, Current medicinal chemistry.

A density functional study of the glycine molecule: Comparison with post‐Hartree–Fock calculations and experiment

D. Nguyen, A. Hagler, D. Salahub, 1997 .

Study of Inhibitors Against SARS Coronavirus by Computational Approaches

K. Chou, Hongbin Shen, Dongqing Wei, 2009, Viral Proteases and Antiviral Protease Inhibitor Therapy.

Aryl O- and S-galactosides and lactosides as specific inhibitors of human galectins-1 and -3: role of electrostatic potential at O-3.

Sachiko Sato, R. Roy, S. Sirois, 2006, Bioorganic & medicinal chemistry letters.

A density functional study of the interaction of CO2 with a Pd atom

D. Salahub, S. Sirois, M. Castro, 1994 .

Mannosylated G(0) Dendrimers with Nanomolar Affinities to Escherichia coli FimH

Qingan Wang, Tze Chieh Shiao, Suzanne Sirois, 2007, ChemMedChem.

Density Functional Description of Metal-Metal and Metal-Ligand Bonds

D. Salahub, C. Jamorski, N. Russo, 1994 .

Glycosylation of HIV-1 gp120 V3 loop: towards the rational design of a synthetic carbohydrate vaccine.

K. Chou, R. Roy, S. Sirois, 2007, Current medicinal chemistry.

Selection of molecular descriptors with artificial intelligence for the understanding of HIV-1 protease peptidomimetic inhibitors-activity.

Kuo-Chen Chou, Dongqing Wei, K. Chou, 2005, Medicinal chemistry (Shariqah (United Arab Emirates)).

Solvation of formic acid and proton transfer in hydrated clusters

D. Salahub, S. Sirois, D. Wei, 2002 .

Hydrogen-bonding in glycine and malonaldehyde: Performance of the Lap1 correlation functional

Dennis R. Salahub, Suzanne Sirois, D. Nguyen, 1997 .

A density functional study of the hydrogen‐bond network within the HIV‐1 protease catalytic site cleft

Dennis R. Salahub, Christos M. Tsoukas, Jean-François Truchon, 2003, J. Comput. Chem..

Bayesian versus Frequentist statistical modeling: a debate for hit selection from HTS campaigns.

L Martin Cloutier, Suzanne Sirois, S. Sirois, 2008, Drug discovery today.

Extension of the LAP functional to include parallel spin correlation

Dennis R. Salahub, D. Salahub, E. Proynov, 1997 .

Molecular modeling and chemical modification for finding peptide inhibitor against severe acute respiratory syndrome coronavirus main proteinase

Kuo-Chen Chou, Qishi Du, Dongqing Wei, 2004, Analytical Biochemistry.

Polyprotein cleavage mechanism of SARS CoV Mpro and chemical modification of the octapeptide

K. Chou, Dongqing Wei, Hong Guo, 2004, Peptides.

Virtual Screening for SARS-CoV Protease Based on KZ7088 Pharmacophore Points

Kuo-Chen Chou, Qishi Du, Dongqing Wei, 2004, J. Chem. Inf. Model..

HIV-1 gp120 V3 loop for structure-based drug design.

Kuo-Chen Chou, Tobias Sing, Suzanne Sirois, 2005, Current protein & peptide science.

Discovery of Potent Anti-SARS-CoV MPro Inhibitors

Dongqing Wei, S. Sirois, Wei-na Gao, 2007 .

A first QSAR model for galectin-3 glycomimetic inhibitors based on 3D docked structures.

R. Roy, S. Sirois, D. Giguère, 2006, Medicinal chemistry.

Needed: system dynamics for the drug discovery process.

L Martin Cloutier, Suzanne Sirois, S. Sirois, 2008, Drug discovery today.

Bayesian versus Frequentist statistical modeling: a debate for hit selection from HTS campaigns.

S. Sirois, L. Cloutier, 2008 .

Assessment of chemical libraries for their druggability

Kuo-Chen Chou, Qishi Du, George E. Hatzakis, 2005, Comput. Biol. Chem..